⌘K

Home/Filings/4/0001209191-19-021442

4//SEC Filing

Berger Dietmar 4

Accession 0001209191-19-021442

CIK 0001604464other

View on SEC.gov Company Profile

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 5:17 PM ET

Size

4.9 KB

Accession

0001209191-19-021442

Insider Transaction Report

Form 4

Period: 2019-03-26

Atara Biotherapeutics, Inc.ATRA

Global Head of R&D

Transactions

Award
Common Stock
2019-03-26+15,000→ 90,000 total

Footnotes (1)

[F1]These restricted stock units vest as to 50% of the shares on March 26, 2020 and 50% of the shares on March 26, 2021, subject to the reporting person's continuous service.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1

filerCIK 0001739515

Filing Metadata

Form type: 4
Filed: Mar 26, 8:00 PM ET
Accepted: Mar 27, 5:17 PM ET
Size: 4.9 KB

View on SEC.gov